— Know what they know.
Not Investment Advice
Also trades as: EXE.TO (TSX) · $vol 10M · 0S9E.L (LSE) · $vol 0M

EXETF OTC

Extendicare Inc.
1W: -9.8% 1M: -12.3% 3M: -23.8% YTD: +30.3% 1Y: +84.2% 3Y: +392.1% 5Y: +316.9%
$19.93
-1.05 (-5.00%)
 
Weekly Expected Move ±13.8%
$14 $17 $20 $23 $25
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 43 · $1.9B mcap · 94M float · 0.097% daily turnover · Short 49% of daily vol

Cash Flow Trends

Operating Cash Flow
$165M +14.9% ▲
5Y CAGR: +6.4%
Capital Expenditures
$102M -142.5% ▼
5Y CAGR: +25.2%
Free Cash Flow
$63M -37.7% ▼
5Y CAGR: -6.4%
Dividends Paid
$42M -4.1% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
$232M +397.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$12M$70M$34M$75M$97M
Depreciation & Amort.$39M$32M$32M$33M$37M
Stock-Based Comp.$4M$3M$3M$2M$0
Change in Working Capital$14M$54M-$41M$23M$57M
Other Non-Cash Items-$10M-$60M-$15M-$14M-$18M
Operating Cash Flow$63M$99M$23M$144M$165M
— Investing Activities —
Capital Expenditures-$70M-$102M-$129M-$42M-$102M
Acquisitions (Net)$0$253M-$25M-$718K-$75M
Investment Purchases$0$0$0$0-$1M
Investment Sales$0$0$0$0$57M
Other Investing$6M$4M$70M$34M$2M
Investing Cash Flow-$64M$156M-$84M-$9M-$119M
— Financing Activities —
Net Debt Issuance-$30M-$114M$19M-$45M$31M
Stock Repurchased$0-$35M-$11M$0$0
Dividends Paid-$43M-$43M-$40M-$40M-$42M
Other Financing-$2M-$56K$2M-$3M$0
Financing Cash Flow-$75M-$192M-$31M-$88M$180M
Net Change in Cash-$75M$63M-$92M$47M$232M
Cash End of Period$105M$167M$75M$122M$349M
Free Cash Flow-$6M-$3M-$106M$102M$63M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms